Global Biopharmaceutical CDMO Service Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Biopharmaceutical CDMO Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharmaceutical CDMO Service Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical CDMO Service market in any manner.
Global Biopharmaceutical CDMO Service Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Market Segmentation (by Type)
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharmaceutical CDMO Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Biopharmaceutical CDMO Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharmaceutical CDMO Service Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical CDMO Service market in any manner.
Global Biopharmaceutical CDMO Service Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Market Segmentation (by Type)
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biopharmaceutical CDMO Service Market
- Overview of the regional outlook of the Biopharmaceutical CDMO Service Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharmaceutical CDMO Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biopharmaceutical CDMO Service
1.2 Key Market Segments
1.2.1 Biopharmaceutical CDMO Service Segment by Type
1.2.2 Biopharmaceutical CDMO Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOPHARMACEUTICAL CDMO SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biopharmaceutical CDMO Service Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biopharmaceutical CDMO Service Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOPHARMACEUTICAL CDMO SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Global Biopharmaceutical CDMO Service Sales by Manufacturers (2019-2024)
3.2 Global Biopharmaceutical CDMO Service Revenue Market Share by Manufacturers (2019-2024)
3.3 Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biopharmaceutical CDMO Service Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biopharmaceutical CDMO Service Sales Sites, Area Served, Product Type
3.6 Biopharmaceutical CDMO Service Market Competitive Situation and Trends
3.6.1 Biopharmaceutical CDMO Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biopharmaceutical CDMO Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO SERVICE INDUSTRY CHAIN ANALYSIS
4.1 Biopharmaceutical CDMO Service Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOPHARMACEUTICAL CDMO SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOPHARMACEUTICAL CDMO SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical CDMO Service Sales Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical CDMO Service Market Size Market Share by Type (2019-2024)
6.4 Global Biopharmaceutical CDMO Service Price by Type (2019-2024)
7 BIOPHARMACEUTICAL CDMO SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical CDMO Service Market Sales by Application (2019-2024)
7.3 Global Biopharmaceutical CDMO Service Market Size (M USD) by Application (2019-2024)
7.4 Global Biopharmaceutical CDMO Service Sales Growth Rate by Application (2019-2024)
8 BIOPHARMACEUTICAL CDMO SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Biopharmaceutical CDMO Service Sales by Region
8.1.1 Global Biopharmaceutical CDMO Service Sales by Region
8.1.2 Global Biopharmaceutical CDMO Service Sales Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical CDMO Service Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical CDMO Service Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical CDMO Service Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical CDMO Service Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical CDMO Service Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 KBI Biopharma
9.1.1 KBI Biopharma Biopharmaceutical CDMO Service Basic Information
9.1.2 KBI Biopharma Biopharmaceutical CDMO Service Product Overview
9.1.3 KBI Biopharma Biopharmaceutical CDMO Service Product Market Performance
9.1.4 KBI Biopharma Business Overview
9.1.5 KBI Biopharma Biopharmaceutical CDMO Service SWOT Analysis
9.1.6 KBI Biopharma Recent Developments
9.2 INCOG BioPharma Services
9.2.1 INCOG BioPharma Services Biopharmaceutical CDMO Service Basic Information
9.2.2 INCOG BioPharma Services Biopharmaceutical CDMO Service Product Overview
9.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Product Market Performance
9.2.4 INCOG BioPharma Services Business Overview
9.2.5 INCOG BioPharma Services Biopharmaceutical CDMO Service SWOT Analysis
9.2.6 INCOG BioPharma Services Recent Developments
9.3 CordenPharma
9.3.1 CordenPharma Biopharmaceutical CDMO Service Basic Information
9.3.2 CordenPharma Biopharmaceutical CDMO Service Product Overview
9.3.3 CordenPharma Biopharmaceutical CDMO Service Product Market Performance
9.3.4 CordenPharma Biopharmaceutical CDMO Service SWOT Analysis
9.3.5 CordenPharma Business Overview
9.3.6 CordenPharma Recent Developments
9.4 AGC Biologics
9.4.1 AGC Biologics Biopharmaceutical CDMO Service Basic Information
9.4.2 AGC Biologics Biopharmaceutical CDMO Service Product Overview
9.4.3 AGC Biologics Biopharmaceutical CDMO Service Product Market Performance
9.4.4 AGC Biologics Business Overview
9.4.5 AGC Biologics Recent Developments
9.5 Northway Biotech
9.5.1 Northway Biotech Biopharmaceutical CDMO Service Basic Information
9.5.2 Northway Biotech Biopharmaceutical CDMO Service Product Overview
9.5.3 Northway Biotech Biopharmaceutical CDMO Service Product Market Performance
9.5.4 Northway Biotech Business Overview
9.5.5 Northway Biotech Recent Developments
9.6 PlantForm Corp
9.6.1 PlantForm Corp Biopharmaceutical CDMO Service Basic Information
9.6.2 PlantForm Corp Biopharmaceutical CDMO Service Product Overview
9.6.3 PlantForm Corp Biopharmaceutical CDMO Service Product Market Performance
9.6.4 PlantForm Corp Business Overview
9.6.5 PlantForm Corp Recent Developments
9.7 Lonza
9.7.1 Lonza Biopharmaceutical CDMO Service Basic Information
9.7.2 Lonza Biopharmaceutical CDMO Service Product Overview
9.7.3 Lonza Biopharmaceutical CDMO Service Product Market Performance
9.7.4 Lonza Business Overview
9.7.5 Lonza Recent Developments
9.8 ADL Biopharma
9.8.1 ADL Biopharma Biopharmaceutical CDMO Service Basic Information
9.8.2 ADL Biopharma Biopharmaceutical CDMO Service Product Overview
9.8.3 ADL Biopharma Biopharmaceutical CDMO Service Product Market Performance
9.8.4 ADL Biopharma Business Overview
9.8.5 ADL Biopharma Recent Developments
9.9 Catalent
9.9.1 Catalent Biopharmaceutical CDMO Service Basic Information
9.9.2 Catalent Biopharmaceutical CDMO Service Product Overview
9.9.3 Catalent Biopharmaceutical CDMO Service Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Future Fields
9.10.1 Future Fields Biopharmaceutical CDMO Service Basic Information
9.10.2 Future Fields Biopharmaceutical CDMO Service Product Overview
9.10.3 Future Fields Biopharmaceutical CDMO Service Product Market Performance
9.10.4 Future Fields Business Overview
9.10.5 Future Fields Recent Developments
9.11 Vetter Pharma
9.11.1 Vetter Pharma Biopharmaceutical CDMO Service Basic Information
9.11.2 Vetter Pharma Biopharmaceutical CDMO Service Product Overview
9.11.3 Vetter Pharma Biopharmaceutical CDMO Service Product Market Performance
9.11.4 Vetter Pharma Business Overview
9.11.5 Vetter Pharma Recent Developments
9.12 Stelis
9.12.1 Stelis Biopharmaceutical CDMO Service Basic Information
9.12.2 Stelis Biopharmaceutical CDMO Service Product Overview
9.12.3 Stelis Biopharmaceutical CDMO Service Product Market Performance
9.12.4 Stelis Business Overview
9.12.5 Stelis Recent Developments
9.13 Richter-Helm
9.13.1 Richter-Helm Biopharmaceutical CDMO Service Basic Information
9.13.2 Richter-Helm Biopharmaceutical CDMO Service Product Overview
9.13.3 Richter-Helm Biopharmaceutical CDMO Service Product Market Performance
9.13.4 Richter-Helm Business Overview
9.13.5 Richter-Helm Recent Developments
9.14 FUJIFILM Diosynth Biotechnologies
9.14.1 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Basic Information
9.14.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Overview
9.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Market Performance
9.14.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.15 Cambrex
9.15.1 Cambrex Biopharmaceutical CDMO Service Basic Information
9.15.2 Cambrex Biopharmaceutical CDMO Service Product Overview
9.15.3 Cambrex Biopharmaceutical CDMO Service Product Market Performance
9.15.4 Cambrex Business Overview
9.15.5 Cambrex Recent Developments
9.16 Pfizer CentreOne
9.16.1 Pfizer CentreOne Biopharmaceutical CDMO Service Basic Information
9.16.2 Pfizer CentreOne Biopharmaceutical CDMO Service Product Overview
9.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Product Market Performance
9.16.4 Pfizer CentreOne Business Overview
9.16.5 Pfizer CentreOne Recent Developments
9.17 Samsung Biologics
9.17.1 Samsung Biologics Biopharmaceutical CDMO Service Basic Information
9.17.2 Samsung Biologics Biopharmaceutical CDMO Service Product Overview
9.17.3 Samsung Biologics Biopharmaceutical CDMO Service Product Market Performance
9.17.4 Samsung Biologics Business Overview
9.17.5 Samsung Biologics Recent Developments
10 BIOPHARMACEUTICAL CDMO SERVICE MARKET FORECAST BY REGION
10.1 Global Biopharmaceutical CDMO Service Market Size Forecast
10.2 Global Biopharmaceutical CDMO Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical CDMO Service Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical CDMO Service Market Size Forecast by Region
10.2.4 South America Biopharmaceutical CDMO Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical CDMO Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biopharmaceutical CDMO Service Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biopharmaceutical CDMO Service by Type (2025-2030)
11.1.2 Global Biopharmaceutical CDMO Service Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biopharmaceutical CDMO Service by Type (2025-2030)
11.2 Global Biopharmaceutical CDMO Service Market Forecast by Application (2025-2030)
11.2.1 Global Biopharmaceutical CDMO Service Sales (K Units) Forecast by Application
11.2.2 Global Biopharmaceutical CDMO Service Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biopharmaceutical CDMO Service
1.2 Key Market Segments
1.2.1 Biopharmaceutical CDMO Service Segment by Type
1.2.2 Biopharmaceutical CDMO Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOPHARMACEUTICAL CDMO SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biopharmaceutical CDMO Service Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biopharmaceutical CDMO Service Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOPHARMACEUTICAL CDMO SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Global Biopharmaceutical CDMO Service Sales by Manufacturers (2019-2024)
3.2 Global Biopharmaceutical CDMO Service Revenue Market Share by Manufacturers (2019-2024)
3.3 Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biopharmaceutical CDMO Service Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biopharmaceutical CDMO Service Sales Sites, Area Served, Product Type
3.6 Biopharmaceutical CDMO Service Market Competitive Situation and Trends
3.6.1 Biopharmaceutical CDMO Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biopharmaceutical CDMO Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO SERVICE INDUSTRY CHAIN ANALYSIS
4.1 Biopharmaceutical CDMO Service Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOPHARMACEUTICAL CDMO SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOPHARMACEUTICAL CDMO SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical CDMO Service Sales Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical CDMO Service Market Size Market Share by Type (2019-2024)
6.4 Global Biopharmaceutical CDMO Service Price by Type (2019-2024)
7 BIOPHARMACEUTICAL CDMO SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical CDMO Service Market Sales by Application (2019-2024)
7.3 Global Biopharmaceutical CDMO Service Market Size (M USD) by Application (2019-2024)
7.4 Global Biopharmaceutical CDMO Service Sales Growth Rate by Application (2019-2024)
8 BIOPHARMACEUTICAL CDMO SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Biopharmaceutical CDMO Service Sales by Region
8.1.1 Global Biopharmaceutical CDMO Service Sales by Region
8.1.2 Global Biopharmaceutical CDMO Service Sales Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical CDMO Service Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical CDMO Service Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical CDMO Service Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical CDMO Service Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical CDMO Service Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 KBI Biopharma
9.1.1 KBI Biopharma Biopharmaceutical CDMO Service Basic Information
9.1.2 KBI Biopharma Biopharmaceutical CDMO Service Product Overview
9.1.3 KBI Biopharma Biopharmaceutical CDMO Service Product Market Performance
9.1.4 KBI Biopharma Business Overview
9.1.5 KBI Biopharma Biopharmaceutical CDMO Service SWOT Analysis
9.1.6 KBI Biopharma Recent Developments
9.2 INCOG BioPharma Services
9.2.1 INCOG BioPharma Services Biopharmaceutical CDMO Service Basic Information
9.2.2 INCOG BioPharma Services Biopharmaceutical CDMO Service Product Overview
9.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Product Market Performance
9.2.4 INCOG BioPharma Services Business Overview
9.2.5 INCOG BioPharma Services Biopharmaceutical CDMO Service SWOT Analysis
9.2.6 INCOG BioPharma Services Recent Developments
9.3 CordenPharma
9.3.1 CordenPharma Biopharmaceutical CDMO Service Basic Information
9.3.2 CordenPharma Biopharmaceutical CDMO Service Product Overview
9.3.3 CordenPharma Biopharmaceutical CDMO Service Product Market Performance
9.3.4 CordenPharma Biopharmaceutical CDMO Service SWOT Analysis
9.3.5 CordenPharma Business Overview
9.3.6 CordenPharma Recent Developments
9.4 AGC Biologics
9.4.1 AGC Biologics Biopharmaceutical CDMO Service Basic Information
9.4.2 AGC Biologics Biopharmaceutical CDMO Service Product Overview
9.4.3 AGC Biologics Biopharmaceutical CDMO Service Product Market Performance
9.4.4 AGC Biologics Business Overview
9.4.5 AGC Biologics Recent Developments
9.5 Northway Biotech
9.5.1 Northway Biotech Biopharmaceutical CDMO Service Basic Information
9.5.2 Northway Biotech Biopharmaceutical CDMO Service Product Overview
9.5.3 Northway Biotech Biopharmaceutical CDMO Service Product Market Performance
9.5.4 Northway Biotech Business Overview
9.5.5 Northway Biotech Recent Developments
9.6 PlantForm Corp
9.6.1 PlantForm Corp Biopharmaceutical CDMO Service Basic Information
9.6.2 PlantForm Corp Biopharmaceutical CDMO Service Product Overview
9.6.3 PlantForm Corp Biopharmaceutical CDMO Service Product Market Performance
9.6.4 PlantForm Corp Business Overview
9.6.5 PlantForm Corp Recent Developments
9.7 Lonza
9.7.1 Lonza Biopharmaceutical CDMO Service Basic Information
9.7.2 Lonza Biopharmaceutical CDMO Service Product Overview
9.7.3 Lonza Biopharmaceutical CDMO Service Product Market Performance
9.7.4 Lonza Business Overview
9.7.5 Lonza Recent Developments
9.8 ADL Biopharma
9.8.1 ADL Biopharma Biopharmaceutical CDMO Service Basic Information
9.8.2 ADL Biopharma Biopharmaceutical CDMO Service Product Overview
9.8.3 ADL Biopharma Biopharmaceutical CDMO Service Product Market Performance
9.8.4 ADL Biopharma Business Overview
9.8.5 ADL Biopharma Recent Developments
9.9 Catalent
9.9.1 Catalent Biopharmaceutical CDMO Service Basic Information
9.9.2 Catalent Biopharmaceutical CDMO Service Product Overview
9.9.3 Catalent Biopharmaceutical CDMO Service Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Future Fields
9.10.1 Future Fields Biopharmaceutical CDMO Service Basic Information
9.10.2 Future Fields Biopharmaceutical CDMO Service Product Overview
9.10.3 Future Fields Biopharmaceutical CDMO Service Product Market Performance
9.10.4 Future Fields Business Overview
9.10.5 Future Fields Recent Developments
9.11 Vetter Pharma
9.11.1 Vetter Pharma Biopharmaceutical CDMO Service Basic Information
9.11.2 Vetter Pharma Biopharmaceutical CDMO Service Product Overview
9.11.3 Vetter Pharma Biopharmaceutical CDMO Service Product Market Performance
9.11.4 Vetter Pharma Business Overview
9.11.5 Vetter Pharma Recent Developments
9.12 Stelis
9.12.1 Stelis Biopharmaceutical CDMO Service Basic Information
9.12.2 Stelis Biopharmaceutical CDMO Service Product Overview
9.12.3 Stelis Biopharmaceutical CDMO Service Product Market Performance
9.12.4 Stelis Business Overview
9.12.5 Stelis Recent Developments
9.13 Richter-Helm
9.13.1 Richter-Helm Biopharmaceutical CDMO Service Basic Information
9.13.2 Richter-Helm Biopharmaceutical CDMO Service Product Overview
9.13.3 Richter-Helm Biopharmaceutical CDMO Service Product Market Performance
9.13.4 Richter-Helm Business Overview
9.13.5 Richter-Helm Recent Developments
9.14 FUJIFILM Diosynth Biotechnologies
9.14.1 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Basic Information
9.14.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Overview
9.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Market Performance
9.14.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.15 Cambrex
9.15.1 Cambrex Biopharmaceutical CDMO Service Basic Information
9.15.2 Cambrex Biopharmaceutical CDMO Service Product Overview
9.15.3 Cambrex Biopharmaceutical CDMO Service Product Market Performance
9.15.4 Cambrex Business Overview
9.15.5 Cambrex Recent Developments
9.16 Pfizer CentreOne
9.16.1 Pfizer CentreOne Biopharmaceutical CDMO Service Basic Information
9.16.2 Pfizer CentreOne Biopharmaceutical CDMO Service Product Overview
9.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Product Market Performance
9.16.4 Pfizer CentreOne Business Overview
9.16.5 Pfizer CentreOne Recent Developments
9.17 Samsung Biologics
9.17.1 Samsung Biologics Biopharmaceutical CDMO Service Basic Information
9.17.2 Samsung Biologics Biopharmaceutical CDMO Service Product Overview
9.17.3 Samsung Biologics Biopharmaceutical CDMO Service Product Market Performance
9.17.4 Samsung Biologics Business Overview
9.17.5 Samsung Biologics Recent Developments
10 BIOPHARMACEUTICAL CDMO SERVICE MARKET FORECAST BY REGION
10.1 Global Biopharmaceutical CDMO Service Market Size Forecast
10.2 Global Biopharmaceutical CDMO Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical CDMO Service Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical CDMO Service Market Size Forecast by Region
10.2.4 South America Biopharmaceutical CDMO Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical CDMO Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biopharmaceutical CDMO Service Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biopharmaceutical CDMO Service by Type (2025-2030)
11.1.2 Global Biopharmaceutical CDMO Service Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biopharmaceutical CDMO Service by Type (2025-2030)
11.2 Global Biopharmaceutical CDMO Service Market Forecast by Application (2025-2030)
11.2.1 Global Biopharmaceutical CDMO Service Sales (K Units) Forecast by Application
11.2.2 Global Biopharmaceutical CDMO Service Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharmaceutical CDMO Service Market Size Comparison by Region (M USD)
Table 5. Global Biopharmaceutical CDMO Service Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biopharmaceutical CDMO Service Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biopharmaceutical CDMO Service Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biopharmaceutical CDMO Service Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2022)
Table 10. Global Market Biopharmaceutical CDMO Service Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biopharmaceutical CDMO Service Sales Sites and Area Served
Table 12. Manufacturers Biopharmaceutical CDMO Service Product Type
Table 13. Global Biopharmaceutical CDMO Service Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biopharmaceutical CDMO Service
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biopharmaceutical CDMO Service Market Challenges
Table 22. Global Biopharmaceutical CDMO Service Sales by Type (K Units)
Table 23. Global Biopharmaceutical CDMO Service Market Size by Type (M USD)
Table 24. Global Biopharmaceutical CDMO Service Sales (K Units) by Type (2019-2024)
Table 25. Global Biopharmaceutical CDMO Service Sales Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CDMO Service Market Size (M USD) by Type (2019-2024)
Table 27. Global Biopharmaceutical CDMO Service Market Size Share by Type (2019-2024)
Table 28. Global Biopharmaceutical CDMO Service Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biopharmaceutical CDMO Service Sales (K Units) by Application
Table 30. Global Biopharmaceutical CDMO Service Market Size by Application
Table 31. Global Biopharmaceutical CDMO Service Sales by Application (2019-2024) & (K Units)
Table 32. Global Biopharmaceutical CDMO Service Sales Market Share by Application (2019-2024)
Table 33. Global Biopharmaceutical CDMO Service Sales by Application (2019-2024) & (M USD)
Table 34. Global Biopharmaceutical CDMO Service Market Share by Application (2019-2024)
Table 35. Global Biopharmaceutical CDMO Service Sales Growth Rate by Application (2019-2024)
Table 36. Global Biopharmaceutical CDMO Service Sales by Region (2019-2024) & (K Units)
Table 37. Global Biopharmaceutical CDMO Service Sales Market Share by Region (2019-2024)
Table 38. North America Biopharmaceutical CDMO Service Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biopharmaceutical CDMO Service Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biopharmaceutical CDMO Service Sales by Region (2019-2024) & (K Units)
Table 41. South America Biopharmaceutical CDMO Service Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biopharmaceutical CDMO Service Sales by Region (2019-2024) & (K Units)
Table 43. KBI Biopharma Biopharmaceutical CDMO Service Basic Information
Table 44. KBI Biopharma Biopharmaceutical CDMO Service Product Overview
Table 45. KBI Biopharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. KBI Biopharma Business Overview
Table 47. KBI Biopharma Biopharmaceutical CDMO Service SWOT Analysis
Table 48. KBI Biopharma Recent Developments
Table 49. INCOG BioPharma Services Biopharmaceutical CDMO Service Basic Information
Table 50. INCOG BioPharma Services Biopharmaceutical CDMO Service Product Overview
Table 51. INCOG BioPharma Services Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. INCOG BioPharma Services Business Overview
Table 53. INCOG BioPharma Services Biopharmaceutical CDMO Service SWOT Analysis
Table 54. INCOG BioPharma Services Recent Developments
Table 55. CordenPharma Biopharmaceutical CDMO Service Basic Information
Table 56. CordenPharma Biopharmaceutical CDMO Service Product Overview
Table 57. CordenPharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. CordenPharma Biopharmaceutical CDMO Service SWOT Analysis
Table 59. CordenPharma Business Overview
Table 60. CordenPharma Recent Developments
Table 61. AGC Biologics Biopharmaceutical CDMO Service Basic Information
Table 62. AGC Biologics Biopharmaceutical CDMO Service Product Overview
Table 63. AGC Biologics Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AGC Biologics Business Overview
Table 65. AGC Biologics Recent Developments
Table 66. Northway Biotech Biopharmaceutical CDMO Service Basic Information
Table 67. Northway Biotech Biopharmaceutical CDMO Service Product Overview
Table 68. Northway Biotech Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Northway Biotech Business Overview
Table 70. Northway Biotech Recent Developments
Table 71. PlantForm Corp Biopharmaceutical CDMO Service Basic Information
Table 72. PlantForm Corp Biopharmaceutical CDMO Service Product Overview
Table 73. PlantForm Corp Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. PlantForm Corp Business Overview
Table 75. PlantForm Corp Recent Developments
Table 76. Lonza Biopharmaceutical CDMO Service Basic Information
Table 77. Lonza Biopharmaceutical CDMO Service Product Overview
Table 78. Lonza Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Lonza Business Overview
Table 80. Lonza Recent Developments
Table 81. ADL Biopharma Biopharmaceutical CDMO Service Basic Information
Table 82. ADL Biopharma Biopharmaceutical CDMO Service Product Overview
Table 83. ADL Biopharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. ADL Biopharma Business Overview
Table 85. ADL Biopharma Recent Developments
Table 86. Catalent Biopharmaceutical CDMO Service Basic Information
Table 87. Catalent Biopharmaceutical CDMO Service Product Overview
Table 88. Catalent Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Catalent Business Overview
Table 90. Catalent Recent Developments
Table 91. Future Fields Biopharmaceutical CDMO Service Basic Information
Table 92. Future Fields Biopharmaceutical CDMO Service Product Overview
Table 93. Future Fields Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Future Fields Business Overview
Table 95. Future Fields Recent Developments
Table 96. Vetter Pharma Biopharmaceutical CDMO Service Basic Information
Table 97. Vetter Pharma Biopharmaceutical CDMO Service Product Overview
Table 98. Vetter Pharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Vetter Pharma Business Overview
Table 100. Vetter Pharma Recent Developments
Table 101. Stelis Biopharmaceutical CDMO Service Basic Information
Table 102. Stelis Biopharmaceutical CDMO Service Product Overview
Table 103. Stelis Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Stelis Business Overview
Table 105. Stelis Recent Developments
Table 106. Richter-Helm Biopharmaceutical CDMO Service Basic Information
Table 107. Richter-Helm Biopharmaceutical CDMO Service Product Overview
Table 108. Richter-Helm Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Richter-Helm Business Overview
Table 110. Richter-Helm Recent Developments
Table 111. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Basic Information
Table 112. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Overview
Table 113. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. FUJIFILM Diosynth Biotechnologies Business Overview
Table 115. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 116. Cambrex Biopharmaceutical CDMO Service Basic Information
Table 117. Cambrex Biopharmaceutical CDMO Service Product Overview
Table 118. Cambrex Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cambrex Business Overview
Table 120. Cambrex Recent Developments
Table 121. Pfizer CentreOne Biopharmaceutical CDMO Service Basic Information
Table 122. Pfizer CentreOne Biopharmaceutical CDMO Service Product Overview
Table 123. Pfizer CentreOne Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Pfizer CentreOne Business Overview
Table 125. Pfizer CentreOne Recent Developments
Table 126. Samsung Biologics Biopharmaceutical CDMO Service Basic Information
Table 127. Samsung Biologics Biopharmaceutical CDMO Service Product Overview
Table 128. Samsung Biologics Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Samsung Biologics Business Overview
Table 130. Samsung Biologics Recent Developments
Table 131. Global Biopharmaceutical CDMO Service Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Biopharmaceutical CDMO Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Biopharmaceutical CDMO Service Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Biopharmaceutical CDMO Service Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Biopharmaceutical CDMO Service Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Biopharmaceutical CDMO Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Biopharmaceutical CDMO Service Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Biopharmaceutical CDMO Service Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Biopharmaceutical CDMO Service Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Biopharmaceutical CDMO Service Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Biopharmaceutical CDMO Service Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Biopharmaceutical CDMO Service Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Biopharmaceutical CDMO Service Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharmaceutical CDMO Service Market Size Comparison by Region (M USD)
Table 5. Global Biopharmaceutical CDMO Service Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biopharmaceutical CDMO Service Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biopharmaceutical CDMO Service Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biopharmaceutical CDMO Service Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2022)
Table 10. Global Market Biopharmaceutical CDMO Service Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biopharmaceutical CDMO Service Sales Sites and Area Served
Table 12. Manufacturers Biopharmaceutical CDMO Service Product Type
Table 13. Global Biopharmaceutical CDMO Service Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biopharmaceutical CDMO Service
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biopharmaceutical CDMO Service Market Challenges
Table 22. Global Biopharmaceutical CDMO Service Sales by Type (K Units)
Table 23. Global Biopharmaceutical CDMO Service Market Size by Type (M USD)
Table 24. Global Biopharmaceutical CDMO Service Sales (K Units) by Type (2019-2024)
Table 25. Global Biopharmaceutical CDMO Service Sales Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CDMO Service Market Size (M USD) by Type (2019-2024)
Table 27. Global Biopharmaceutical CDMO Service Market Size Share by Type (2019-2024)
Table 28. Global Biopharmaceutical CDMO Service Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biopharmaceutical CDMO Service Sales (K Units) by Application
Table 30. Global Biopharmaceutical CDMO Service Market Size by Application
Table 31. Global Biopharmaceutical CDMO Service Sales by Application (2019-2024) & (K Units)
Table 32. Global Biopharmaceutical CDMO Service Sales Market Share by Application (2019-2024)
Table 33. Global Biopharmaceutical CDMO Service Sales by Application (2019-2024) & (M USD)
Table 34. Global Biopharmaceutical CDMO Service Market Share by Application (2019-2024)
Table 35. Global Biopharmaceutical CDMO Service Sales Growth Rate by Application (2019-2024)
Table 36. Global Biopharmaceutical CDMO Service Sales by Region (2019-2024) & (K Units)
Table 37. Global Biopharmaceutical CDMO Service Sales Market Share by Region (2019-2024)
Table 38. North America Biopharmaceutical CDMO Service Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biopharmaceutical CDMO Service Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biopharmaceutical CDMO Service Sales by Region (2019-2024) & (K Units)
Table 41. South America Biopharmaceutical CDMO Service Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biopharmaceutical CDMO Service Sales by Region (2019-2024) & (K Units)
Table 43. KBI Biopharma Biopharmaceutical CDMO Service Basic Information
Table 44. KBI Biopharma Biopharmaceutical CDMO Service Product Overview
Table 45. KBI Biopharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. KBI Biopharma Business Overview
Table 47. KBI Biopharma Biopharmaceutical CDMO Service SWOT Analysis
Table 48. KBI Biopharma Recent Developments
Table 49. INCOG BioPharma Services Biopharmaceutical CDMO Service Basic Information
Table 50. INCOG BioPharma Services Biopharmaceutical CDMO Service Product Overview
Table 51. INCOG BioPharma Services Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. INCOG BioPharma Services Business Overview
Table 53. INCOG BioPharma Services Biopharmaceutical CDMO Service SWOT Analysis
Table 54. INCOG BioPharma Services Recent Developments
Table 55. CordenPharma Biopharmaceutical CDMO Service Basic Information
Table 56. CordenPharma Biopharmaceutical CDMO Service Product Overview
Table 57. CordenPharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. CordenPharma Biopharmaceutical CDMO Service SWOT Analysis
Table 59. CordenPharma Business Overview
Table 60. CordenPharma Recent Developments
Table 61. AGC Biologics Biopharmaceutical CDMO Service Basic Information
Table 62. AGC Biologics Biopharmaceutical CDMO Service Product Overview
Table 63. AGC Biologics Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AGC Biologics Business Overview
Table 65. AGC Biologics Recent Developments
Table 66. Northway Biotech Biopharmaceutical CDMO Service Basic Information
Table 67. Northway Biotech Biopharmaceutical CDMO Service Product Overview
Table 68. Northway Biotech Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Northway Biotech Business Overview
Table 70. Northway Biotech Recent Developments
Table 71. PlantForm Corp Biopharmaceutical CDMO Service Basic Information
Table 72. PlantForm Corp Biopharmaceutical CDMO Service Product Overview
Table 73. PlantForm Corp Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. PlantForm Corp Business Overview
Table 75. PlantForm Corp Recent Developments
Table 76. Lonza Biopharmaceutical CDMO Service Basic Information
Table 77. Lonza Biopharmaceutical CDMO Service Product Overview
Table 78. Lonza Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Lonza Business Overview
Table 80. Lonza Recent Developments
Table 81. ADL Biopharma Biopharmaceutical CDMO Service Basic Information
Table 82. ADL Biopharma Biopharmaceutical CDMO Service Product Overview
Table 83. ADL Biopharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. ADL Biopharma Business Overview
Table 85. ADL Biopharma Recent Developments
Table 86. Catalent Biopharmaceutical CDMO Service Basic Information
Table 87. Catalent Biopharmaceutical CDMO Service Product Overview
Table 88. Catalent Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Catalent Business Overview
Table 90. Catalent Recent Developments
Table 91. Future Fields Biopharmaceutical CDMO Service Basic Information
Table 92. Future Fields Biopharmaceutical CDMO Service Product Overview
Table 93. Future Fields Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Future Fields Business Overview
Table 95. Future Fields Recent Developments
Table 96. Vetter Pharma Biopharmaceutical CDMO Service Basic Information
Table 97. Vetter Pharma Biopharmaceutical CDMO Service Product Overview
Table 98. Vetter Pharma Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Vetter Pharma Business Overview
Table 100. Vetter Pharma Recent Developments
Table 101. Stelis Biopharmaceutical CDMO Service Basic Information
Table 102. Stelis Biopharmaceutical CDMO Service Product Overview
Table 103. Stelis Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Stelis Business Overview
Table 105. Stelis Recent Developments
Table 106. Richter-Helm Biopharmaceutical CDMO Service Basic Information
Table 107. Richter-Helm Biopharmaceutical CDMO Service Product Overview
Table 108. Richter-Helm Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Richter-Helm Business Overview
Table 110. Richter-Helm Recent Developments
Table 111. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Basic Information
Table 112. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Overview
Table 113. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. FUJIFILM Diosynth Biotechnologies Business Overview
Table 115. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 116. Cambrex Biopharmaceutical CDMO Service Basic Information
Table 117. Cambrex Biopharmaceutical CDMO Service Product Overview
Table 118. Cambrex Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cambrex Business Overview
Table 120. Cambrex Recent Developments
Table 121. Pfizer CentreOne Biopharmaceutical CDMO Service Basic Information
Table 122. Pfizer CentreOne Biopharmaceutical CDMO Service Product Overview
Table 123. Pfizer CentreOne Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Pfizer CentreOne Business Overview
Table 125. Pfizer CentreOne Recent Developments
Table 126. Samsung Biologics Biopharmaceutical CDMO Service Basic Information
Table 127. Samsung Biologics Biopharmaceutical CDMO Service Product Overview
Table 128. Samsung Biologics Biopharmaceutical CDMO Service Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Samsung Biologics Business Overview
Table 130. Samsung Biologics Recent Developments
Table 131. Global Biopharmaceutical CDMO Service Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Biopharmaceutical CDMO Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Biopharmaceutical CDMO Service Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Biopharmaceutical CDMO Service Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Biopharmaceutical CDMO Service Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Biopharmaceutical CDMO Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Biopharmaceutical CDMO Service Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Biopharmaceutical CDMO Service Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Biopharmaceutical CDMO Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Biopharmaceutical CDMO Service Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Biopharmaceutical CDMO Service Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Biopharmaceutical CDMO Service Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Biopharmaceutical CDMO Service Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Biopharmaceutical CDMO Service Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biopharmaceutical CDMO Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharmaceutical CDMO Service Market Size (M USD), 2019-2030
Figure 5. Global Biopharmaceutical CDMO Service Market Size (M USD) (2019-2030)
Figure 6. Global Biopharmaceutical CDMO Service Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biopharmaceutical CDMO Service Market Size by Country (M USD)
Figure 11. Biopharmaceutical CDMO Service Sales Share by Manufacturers in 2023
Figure 12. Global Biopharmaceutical CDMO Service Revenue Share by Manufacturers in 2023
Figure 13. Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biopharmaceutical CDMO Service Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biopharmaceutical CDMO Service Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biopharmaceutical CDMO Service Market Share by Type
Figure 18. Sales Market Share of Biopharmaceutical CDMO Service by Type (2019-2024)
Figure 19. Sales Market Share of Biopharmaceutical CDMO Service by Type in 2023
Figure 20. Market Size Share of Biopharmaceutical CDMO Service by Type (2019-2024)
Figure 21. Market Size Market Share of Biopharmaceutical CDMO Service by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biopharmaceutical CDMO Service Market Share by Application
Figure 24. Global Biopharmaceutical CDMO Service Sales Market Share by Application (2019-2024)
Figure 25. Global Biopharmaceutical CDMO Service Sales Market Share by Application in 2023
Figure 26. Global Biopharmaceutical CDMO Service Market Share by Application (2019-2024)
Figure 27. Global Biopharmaceutical CDMO Service Market Share by Application in 2023
Figure 28. Global Biopharmaceutical CDMO Service Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biopharmaceutical CDMO Service Sales Market Share by Region (2019-2024)
Figure 30. North America Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biopharmaceutical CDMO Service Sales Market Share by Country in 2023
Figure 32. U.S. Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biopharmaceutical CDMO Service Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biopharmaceutical CDMO Service Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biopharmaceutical CDMO Service Sales Market Share by Country in 2023
Figure 37. Germany Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biopharmaceutical CDMO Service Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biopharmaceutical CDMO Service Sales Market Share by Region in 2023
Figure 44. China Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biopharmaceutical CDMO Service Sales and Growth Rate (K Units)
Figure 50. South America Biopharmaceutical CDMO Service Sales Market Share by Country in 2023
Figure 51. Brazil Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biopharmaceutical CDMO Service Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biopharmaceutical CDMO Service Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biopharmaceutical CDMO Service Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biopharmaceutical CDMO Service Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biopharmaceutical CDMO Service Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biopharmaceutical CDMO Service Market Share Forecast by Type (2025-2030)
Figure 65. Global Biopharmaceutical CDMO Service Sales Forecast by Application (2025-2030)
Figure 66. Global Biopharmaceutical CDMO Service Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biopharmaceutical CDMO Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharmaceutical CDMO Service Market Size (M USD), 2019-2030
Figure 5. Global Biopharmaceutical CDMO Service Market Size (M USD) (2019-2030)
Figure 6. Global Biopharmaceutical CDMO Service Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biopharmaceutical CDMO Service Market Size by Country (M USD)
Figure 11. Biopharmaceutical CDMO Service Sales Share by Manufacturers in 2023
Figure 12. Global Biopharmaceutical CDMO Service Revenue Share by Manufacturers in 2023
Figure 13. Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biopharmaceutical CDMO Service Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biopharmaceutical CDMO Service Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biopharmaceutical CDMO Service Market Share by Type
Figure 18. Sales Market Share of Biopharmaceutical CDMO Service by Type (2019-2024)
Figure 19. Sales Market Share of Biopharmaceutical CDMO Service by Type in 2023
Figure 20. Market Size Share of Biopharmaceutical CDMO Service by Type (2019-2024)
Figure 21. Market Size Market Share of Biopharmaceutical CDMO Service by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biopharmaceutical CDMO Service Market Share by Application
Figure 24. Global Biopharmaceutical CDMO Service Sales Market Share by Application (2019-2024)
Figure 25. Global Biopharmaceutical CDMO Service Sales Market Share by Application in 2023
Figure 26. Global Biopharmaceutical CDMO Service Market Share by Application (2019-2024)
Figure 27. Global Biopharmaceutical CDMO Service Market Share by Application in 2023
Figure 28. Global Biopharmaceutical CDMO Service Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biopharmaceutical CDMO Service Sales Market Share by Region (2019-2024)
Figure 30. North America Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biopharmaceutical CDMO Service Sales Market Share by Country in 2023
Figure 32. U.S. Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biopharmaceutical CDMO Service Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biopharmaceutical CDMO Service Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biopharmaceutical CDMO Service Sales Market Share by Country in 2023
Figure 37. Germany Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biopharmaceutical CDMO Service Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biopharmaceutical CDMO Service Sales Market Share by Region in 2023
Figure 44. China Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biopharmaceutical CDMO Service Sales and Growth Rate (K Units)
Figure 50. South America Biopharmaceutical CDMO Service Sales Market Share by Country in 2023
Figure 51. Brazil Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biopharmaceutical CDMO Service Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biopharmaceutical CDMO Service Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biopharmaceutical CDMO Service Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biopharmaceutical CDMO Service Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biopharmaceutical CDMO Service Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biopharmaceutical CDMO Service Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biopharmaceutical CDMO Service Market Share Forecast by Type (2025-2030)
Figure 65. Global Biopharmaceutical CDMO Service Sales Forecast by Application (2025-2030)
Figure 66. Global Biopharmaceutical CDMO Service Market Share Forecast by Application (2025-2030)
